Carotid thickening, cardiac hypertrophy, and angiotensin converting enzyme gene polymorphism in patients with hypertension

American Journal of Hypertension

Volumn 13, Issue 1 II SUPPL., 2000, Pages 111-119

  Jeng, Jing Ren ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Angiotensin converting enzyme; Cardiac hypertrophy; Carotid atherosclerosis; Gene polymorphism; Hypertension

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTERY INTIMA; ATHEROSCLEROSIS; BODY MASS; CAROTID ARTERY BIFURCATION; CAROTID ARTERY OBSTRUCTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART HYPERTROPHY; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW; SYSTOLIC BLOOD PRESSURE;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOMEGALY; CAROTID ARTERIES; DNA; ECHOCARDIOGRAPHY; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS;

EID: 0033951482     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(99)00193-4     Document Type: Article

References (47)

1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
2. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
3. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin I-converting enzyme in human peripheral mononuclear cells: main expression in T-lymphocytes under the influence of a genetic polymorphism. Biochem J 1993;290:33-40.
4. Cambien F, Poirer O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (Lond.) 1992;359:641-644.
5. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994; 90:2199-2202.
6. Raynolds MV, Bristor MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB: Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-1075.
7. Harn HJ, Chang CY, Ho LI, Liu CA, Jeng JR, Lin FG, Wei J: Evidence that polymorphism of the angiotensin I converting enzyme gene may be related to idiopathic dilated cardiomyopathy in the Chinese population. Biochem Mol Biol Int 1995;35:1175-1181.
8. Marian AJ, Yu Q-T, Workman R, Greve G, Roberts R: Angiotensin-converting enzyme gene polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993;342:1085-1086.
9. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM: Absence of linkage between the angiotensin converting enzyme locus and human hypertension. Nat Genet 1992;1:72-75.
10. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJW, Watt GCM: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993;21:455-460.
11. Schmidt S, van Hooft IMS, Grobbee DE, Ganten D, Ritz E: Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring study. J Hypertens 1993;11:345-348.
12. Gu XX, Spaepen M, Guo G, Fagard R, Amery A, Lijnen P, Cassiman J-J: Lack of association between the I/D polymorphism of the angiotensin-converting enzyme gene and essential hypertension in a Belgian population. J Hum Hypertens 1994;8:683-685.
13. Ishigami T, Iwamoto T, Tamura K, Yamaguchi S, Iwasawa K, Uchino K, Umemura S, Ishii M: Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japanese: ethnic difference of ACE genotype. Am J Hypertens 1995;8:95-97.
14. Maguchi M, Kohara K, Okura T, Li A, Takezaki M, Nishida W, Hiwada K: Angiotensin-converting enzyme gene polymorphism in essential hypertensive patients in Japanese population. Angiology 1996;47:643-648.
15. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, Miki T, Mikami G, Ogihara T: Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun 1993;191:399-404.
16. Jeng JR, Harn HJ, Jeng CY, Yueh KC, Shieh SM: Angiotensin I converting enzyme gene polymorphism in Chinese patients with hypertension. Am J Hypertens 1997; 10:558-561.
17. Castellano M, Muiesan ML, Rizzoni D, Beschi M, Pasini G, Cinelli A, Salvetti M, Porteri E, Bettoni G, Kreutz R, Lindpaintner K, Rosei EA: Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population: the Vobarno study. Circulation 1995;91:2721-2724.
18. Kauma H, Päivänsalo M, Savolainen MJ, Rantala AO, Kiema T-R, Lilja M, Reunanen A, Kesäniemi YA: Association between angiotensin converting enzyme polymorphism and carotid atherosclerosis. J Hypertens 1996;14:1183-1187.
19. Hosoi M, Nishizawa Y, Kogawa K, Kawagishi T, Konishi T, Maekawa K, Wmoto M, Fukumoto S, Shioi A, Shoji T, Inaba M, Okuno Y, Mori H: Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin dependent diabetic patients. Circulation 1996;94:704-707.
20. Dessì-Fulgheri P, Catalini R, Sarzani R, Sturbini S, Siragusa N, Guazzarotti F, Offidani M, Tamburrini P, Zingaretti O, Rappelli A: Angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in a low risk population. J Hypertens 1995;13:1593-1596.
21. Markus HS, Barley J, Lunt R, Bland M, Jeffery S, Carter ND, Brown MM: Angiotensin-converting enzyme gene deletion polymorphism: a new risk factor for lacuna stroke but not carotid atheroma. Stroke 1995;26:1329-1333.
22. Iwai N, Ohmichi N, Jakamura Y, Kinoshita M: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994;90:2622-2628.
23. Ohishi M, Rakugi H, Ogihara T: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994:1097-1098.
24. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Ulrich K, Lorell BH, Riegger GAJ: Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638.
25. Perticone F, Ceravolo R, Cosco C, Trapasso M, Zingone A, Malatesta P, Perrotti N, Tramontano D, Mattioli PL: Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. J Am Coll Cardiol 1997;29:365-369.
26. Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F, Paolo GP, Borgia L, Bobola N, Ravazzolo R, Sacchi G, Deferrari G: The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol 1996;7:2550-2558.
27. Lindpaintner K, Lee M, Larson MG, Rao VS, Pfeffer MA, Ordovas JM, Schaefer EJ, Wilson AF, Wilson PWF, Vasan RS, Myers RH, Levy D: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996;334:1023-1028.
28. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen J: Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994;267:H1107-H1111.
29. Wong KK, Summers KM, Burstow DJ, West MJ: Angiotensin-converting enzyme and angiotensinogen genes in patterns of left ventricular hypertrophy and in diastolic dysfunction. Clin Exper Pharmacol Physiol 1995; 22:438-440.
30. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH: A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
31. Miettinen HE, Korpela K, Hamalainen L, Kontula K: Polymorphism of the apolipoprotein and angiotensin converting enzyme in young North Karelian patients with coronary heart disease. Hum Genet 1994;94:189-192.
32. Zee RYZ, Lou Y, Griffiths LR, Morris BJ: Association of a polymorphism of the angiotensin I converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992;14:9-15.
33. Duru K, Farrow S, Wang JM, Lockette W, Kurtz T: Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens 1994;7: 759-762.
34. Morise T, Takeuchi Y, Takeda R: Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet 1994;343:125.
35. Ming J, Xinmin C, Jianfeng H, Jianhua Q, Guozhang L, Jiarui W, Dan B, Deren Q, Fen ZJ, Shaoru F, Lisheng L: Polymorphism of angiotensin I converting enzyme gene in the older Chinese: linked to ambulatory blood pressure levels and circadian blood pressure rhythm. Int J Cardiol 1996;55:33-40.
36. Jeng JR, Shieh SM, Harn HJ, Lee MMS, Sheu WHH, Jeng CY: Angiotensin I converting enzyme polymorphism and insulin resistance in patients with hypertension. J Hypertens 1997;15:963-968.
37. Jeng JR, Harn HJ, Yueh KC, Jeng CY, Shieh SM: Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension. Am J Hypertens 1998;11:235-239.
38. Jeng JR, Sheu WHH, Jeng CY, Huang SH, Shieh SM: Impaired fibrinolysis and insulin resistance in patients with hypertension. Am J Hypertens 1996;9:484-490.
39. Devereux RB, Casale PN, Kligfield P, Eisenberg RR, Miller D, Campo E, Alonso DR: Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am J Cardiol 1986;57:1388-1393.
40. Sahn DJ, De Maria A, Kisslo J, Weyman A for the committee on M-mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
41. Devereux RB, Reicheck N: Echocardiographic determination of left ventricular mass: anatomic validation of the method. Circulation 1977;55:613-618.
42. Pignoli P, Tremoli E, Poli A, Orestel P, Paoletti R: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74: 1399-1406.
43. Rutledge DR, Kubilis P, Browe CS, Ross EA: Polymorphism of the angiotensin I converting enzyme gene in essential hypertensive patients. Biochem Mol Biol Int 1995;35:661-668.
44. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ: Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest 1994;94:978-984.
45. Dahlof B, Pennert K, Hansson L: Regression of left ventricular hypertrophy: a meta-analysis. Clin Exp Hypertens [A] 1992;14:173-180.
46. Sadoshima JI, Izumo S: Molecular characterization of angiotensin II induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblast: critical role of the AT1 receptor subtype. Circ Res 1993;73:413-423.
47. Farhy RD, Ho KL, Carretero OA, Scicli AG: Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun 1992; 182:283-288.